1. Home
  2. AKR vs TARS Comparison

AKR vs TARS Comparison

Compare AKR & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acadia Realty Trust

AKR

Acadia Realty Trust

HOLD

Current Price

$21.34

Market Cap

2.9B

Sector

Real Estate

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$59.89

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKR
TARS
Founded
1993
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.7B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
AKR
TARS
Price
$21.34
$59.89
Analyst Decision
Buy
Buy
Analyst Count
4
6
Target Price
$22.25
$89.00
AVG Volume (30 Days)
1.8M
1.2M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
3.69%
N/A
EPS Growth
N/A
48.21
EPS
0.22
N/A
Revenue
$410,757,000.00
$451,360,000.00
Revenue This Year
$3.21
$56.43
Revenue Next Year
$12.17
$30.19
P/E Ratio
$96.77
N/A
Revenue Growth
14.20
146.71
52 Week Low
$18.06
$38.51
52 Week High
$22.90
$85.25

Technical Indicators

Market Signals
Indicator
AKR
TARS
Relative Strength Index (RSI) 47.18 43.88
Support Level $20.82 $59.16
Resistance Level $21.62 $67.14
Average True Range (ATR) 0.35 4.52
MACD -0.02 -0.47
Stochastic Oscillator 41.73 20.11

Price Performance

Historical Comparison
AKR
TARS

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: REIT Portfolio segment consists of high-quality retail properties located in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds the retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: